Twin Peaks Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Twin Peaks Wealth Advisors's XBI Position: Q1 2026 in Review
Twin Peaks Wealth Advisors opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 367 shares worth $46.9K. The stake represents 0.01% of the portfolio and ranks #450 among its holdings. This is a return to the name: Twin Peaks Wealth Advisors previously reported a position in XBI as recently as Q2 2025.
Twin Peaks Wealth Advisors first reported a position in XBI in Q2 2025 and has held it in 2 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Twin Peaks Wealth Advisors held 367 shares of State Street SPDR S&P Biotech ETF worth $46.9K as of Q1 2026.
- State Street SPDR S&P Biotech ETF was a new Twin Peaks Wealth Advisors position in Q1 2026.
- State Street SPDR S&P Biotech ETF made up 0.01% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #450 holding.
- Twin Peaks Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2025 and has held it in 2 quarters since.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.